Surgical management of and long-term survival after adenocarcinoma of the cardia

被引:104
作者
Mariette, C [1 ]
Castel, B [1 ]
Toursel, H [1 ]
Fabre, S [1 ]
Balon, JM [1 ]
Triboulet, JP [1 ]
机构
[1] Ctr Hosp Reg & Univ Lille, Hop Claude Huriez, Serv Chirurg Digest & Gen, F-59037 Lille, France
关键词
D O I
10.1046/j.1365-2168.2002.02185.x
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: The choice of surgical strategy for patients with adenocarcinoma of the oesophagogastric junction is controversial. This study was performed to analyse the surgical results of a 20-year experience with these lesions. Methods: From January 1981 to January 2001, 126 patients with adenocarcinoma of the cardia underwent resection in the authors' institution. The treatment of choice was oesophagectomy for type I tumours, and extended gastrectomy for type II and III lesions. Morbidity, mortality and survival were determined retrospectively. Results: Fifty-six patients (44.4 per cent) had type I tumours, 44 (34.9 per cent) type II and 26 (20.6 per cent) type III. Primary resection was performed in 113 patients (89.7 per cent). Oesophagectomy with resection of the proximal stomach was carried out in 65 patients (51.6 per cent) and extended total gastrectomy with transhiatal resection of the distal oesophagus in 61 (48.4 per cent). In-hospital mortality and morbidity rates were 4.8 and 34.1 per cent respectively. The overall 3- and 5-year survival rates were 40.9 and 25.1 per cent respectively, and were not affected by the surgical approach. Survival was significantly associated with R0 resection, pathological node-positive category, postoperative complications and tumour differentiation. Conclusion: Postoperative mortality, morbidity and long-term survival did not appear to be affected by surgical approach. Further prospective studies are needed to confirm the equivalence between transthoracic and transabdominal approaches.
引用
收藏
页码:1156 / 1163
页数:8
相关论文
共 41 条
[1]
[Anonymous], 1997, AJCC CANC STAGING MA
[2]
Extended lymph-node dissection for gastric cancer [J].
Bonenkamp, JJ ;
Hermans, J ;
Sasako, M ;
van de Velde, CJH .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (12) :908-914
[3]
Bumm R, 1997, WORLD J SURG, V21, P822
[4]
A prospective randomized comparison of transhiatal and transthoracic resection for lower-third esophageal carcinoma [J].
Chu, KM ;
Law, SYK ;
Fok, M ;
Wong, J .
AMERICAN JOURNAL OF SURGERY, 1997, 174 (03) :320-324
[5]
Postoperative morbidity and mortality after D-1 and D-2 resections for gastric cancer: Preliminary results of the MRC randomised controlled surgical trial [J].
Cuschieri, A ;
Fayers, P ;
Fielding, J ;
Craven, J ;
Bancewicz, J ;
Joypaul, V ;
Cook, P .
LANCET, 1996, 347 (9007) :995-999
[6]
Devesa SS, 1998, CANCER, V83, P2049, DOI 10.1002/(SICI)1097-0142(19981115)83:10<2049::AID-CNCR1>3.3.CO
[7]
2-U
[8]
Opposing time trends of peptic ulcer and reflux disease [J].
El-Serag, HB ;
Sonnenberg, A .
GUT, 1998, 43 (03) :327-333
[9]
Esophagogastrectomy for carcinoma of the esophagus and cardia: A comparison of findings and results after standard resection in three consecutive eight-year intervals with improved staging criteria [J].
Ellis, FH ;
Heatley, GJ ;
Krasna, MJ ;
Williamson, WA ;
Balogh, K .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1997, 113 (05) :836-846
[10]
Application of the new classification for cancer of the cardia [J].
Fein, M ;
Fuchs, KH ;
Ritter, MP ;
Freys, SM ;
Heimbucher, J ;
Staab, C ;
Thiede, A .
SURGERY, 1998, 124 (04) :707-714